Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Hare KJ, Vilsboll T, Asmar M, Deacon CF, Knop FK, and Holst JJ
Similar results were seen in the non-inferiority HARMONY 7 trial, which compared liraglutide versus albiglutide [46]
Eli Lilly has historically prioritized R&D, but shows signs of shifting toward greater shareholder enrichment: With a ratio of 0.61, Eli Lilly spent more on R&D than on shareholder returns from 2020 to 2024
Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink
Curr Heart Fail Rep
US$ 27.34
US$ 22.12
US$ 26.21
US$ 26.09
